Asia-Pacific Pen Needles Market growing at a CAGR of 14.10% by 2021
Asia-Pacific Pen Needles Market by Therapy (Growth Hormone, Insulin, & GLP-1), Type (Safety Pen Needles, Standard Pen Needles,), Needle Length (4mm, 6mm, 8mm, 10mm, & 12mm), and Mode of Purchase (Retail & Non-Retail)
(EMAILWIRE.COM, September 05, 2017 ) According to the report Asia Pacific pen needles market, published by Market Data Forecast, the Market is expected to reach USD 0.61 billion by 2021 from USD 0.32 billion in 2016, growing at a CAGR of 14.10% for the next five years 2016-2021. Pen needles are used to deliver the medication (such as insulin or other injectable medications) in combination with injection pens. A pen needle comprises of hollow needle attached to injection pen. Pen needles are available with varied needle lengths and are majorly utilized by diabetes patients.
Quickly rising diabetic population, growing number of awareness programs on diabetes conditions, and increasing adoption of pen devices for insulin delivery are driving the growth of pen needles market in Asia-Pacific region. However, increasing reuse of pen needles, limited acceptance of diabetic patients towards the pen needles, and higher cost of the pen needles as compared to conventional syringes & vials are restraining the growth of Asia-Pacific pen needles market.
Browse market data tables and in-depth TOC of the Asia Pacific Pen Needles Industry to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-pen-needles-market-180/
Asia-Pacific pen needles market is segmented based on the therapy, type, needle length, and mode of purchase. On the based on therapy the market is further sub-segmented as insulin therapy, glucose like peptide-1 (GLP-1) therapy, and growth hormone therapy. The market, by type, is sub-segmented as safety needles and standard needles. The needle lengths include 4mm, 6mm, 8mm, 10mm, & 12mm. Based on mode of purchase the market is further sub-segmented as retail & non-retail purchase modes.
Based on therapy, insulin therapy is estimated to command the largest share of the Asia-Pacific pen needles market in 2016 and expected to grow at the highest CAGR during the forecast period 2016-2021. Based on type, standard pen needle segment is estimated to account for larger share of Asia-Pacific pen needles market in 2016, whereas safety pen needles segments is estimated to grow at a higher CAGR for the next five years (2016-2021).
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-pen-needles-market-180/request-sample
Among the length of pen needles, 8mm is estimated to command for the largest share of the Asia-Pacific pen needles market in 2016 and 4mm is expected to grow at the highest CAGR during the forecast period. Based on the mode of purchase retail purchase mode is estimated to account for larger share of the Asia-Pacific pen needles market in 2016 and expected to grow at a higher CAGR for the next five years (2016-2021).
On the basis of geographical areas, Asia-Pacific pen needles market is segmented as Japan, China, and India. Japan is estimated to account for the largest share of the Asia-Pacific pen needles market in 2016, whereas India is estimated to grow at the highest CAGR during the forecast period 2016-2021.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-pen-needles-market-180/inquire
Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), and Ypsomed Holding AG (Switzerland) are the major players accounting for major share of the Asia-Pacific pen needles market in 2016. Other players include UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), and Terumo Corporation (Japan), among others.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Quickly rising diabetic population, growing number of awareness programs on diabetes conditions, and increasing adoption of pen devices for insulin delivery are driving the growth of pen needles market in Asia-Pacific region. However, increasing reuse of pen needles, limited acceptance of diabetic patients towards the pen needles, and higher cost of the pen needles as compared to conventional syringes & vials are restraining the growth of Asia-Pacific pen needles market.
Browse market data tables and in-depth TOC of the Asia Pacific Pen Needles Industry to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-pen-needles-market-180/
Asia-Pacific pen needles market is segmented based on the therapy, type, needle length, and mode of purchase. On the based on therapy the market is further sub-segmented as insulin therapy, glucose like peptide-1 (GLP-1) therapy, and growth hormone therapy. The market, by type, is sub-segmented as safety needles and standard needles. The needle lengths include 4mm, 6mm, 8mm, 10mm, & 12mm. Based on mode of purchase the market is further sub-segmented as retail & non-retail purchase modes.
Based on therapy, insulin therapy is estimated to command the largest share of the Asia-Pacific pen needles market in 2016 and expected to grow at the highest CAGR during the forecast period 2016-2021. Based on type, standard pen needle segment is estimated to account for larger share of Asia-Pacific pen needles market in 2016, whereas safety pen needles segments is estimated to grow at a higher CAGR for the next five years (2016-2021).
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-pen-needles-market-180/request-sample
Among the length of pen needles, 8mm is estimated to command for the largest share of the Asia-Pacific pen needles market in 2016 and 4mm is expected to grow at the highest CAGR during the forecast period. Based on the mode of purchase retail purchase mode is estimated to account for larger share of the Asia-Pacific pen needles market in 2016 and expected to grow at a higher CAGR for the next five years (2016-2021).
On the basis of geographical areas, Asia-Pacific pen needles market is segmented as Japan, China, and India. Japan is estimated to account for the largest share of the Asia-Pacific pen needles market in 2016, whereas India is estimated to grow at the highest CAGR during the forecast period 2016-2021.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-pen-needles-market-180/inquire
Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), and Ypsomed Holding AG (Switzerland) are the major players accounting for major share of the Asia-Pacific pen needles market in 2016. Other players include UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), and Terumo Corporation (Japan), among others.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results